These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7650381)

  • 1. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.
    Flynn JL; Goldstein MM; Triebold KJ; Sypek J; Wolf S; Bloom BR
    J Immunol; 1995 Sep; 155(5):2515-24. PubMed ID: 7650381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice.
    Yi Z; Fu Y; Yang C; Li J; Luo X; Chen Q; Zeng W; Jiang S; Jiang Y; He Y; Yang J; Liu Y; Li N; Zhu DY
    Vaccine; 2007 Jan; 25(4):638-48. PubMed ID: 17000035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BCG-induced T cell anergy and its activation by IL-4].
    Nishioka Y; Nakanishi K; Sugita M
    Arerugi; 1998 May; 47(5):533-42. PubMed ID: 9656576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis.
    Caruso AM; Serbina N; Klein E; Triebold K; Bloom BR; Flynn JL
    J Immunol; 1999 May; 162(9):5407-16. PubMed ID: 10228018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
    Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
    Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
    Kim SH; Cho D; Kim TS
    Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice.
    Buccheri S; Reljic R; Caccamo N; Ivanyi J; Singh M; Salerno A; Dieli F
    Eur J Immunol; 2007 Mar; 37(3):729-37. PubMed ID: 17304630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
    Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
    Cooper AM; Roberts AD; Rhoades ER; Callahan JE; Getzy DM; Orme IM
    Immunology; 1995 Mar; 84(3):423-32. PubMed ID: 7751026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
    Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
    J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effect of interleukin-12 on murine infection with Mycobacterium tuberculosis through modulating Th1 and Th2 cytokine balance].
    Zhang T; Kawakami K; Tang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):358-60. PubMed ID: 11778519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM; Bonafonte MT; Campbell LD; Mead JR
    Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.
    Kawakami K; Hossain Qureshi M; Zhang T; Koguchi Y; Xie Q; Kurimoto M; Saito A
    Cell Immunol; 1999 Oct; 197(1):55-61. PubMed ID: 10555996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.